Trikafta 100 mg / 50 mg / 75 mg, 150 mg, Filmtabletten - 84 Swissmedic Key 67773001 Registration Holder Vertex Pharmaceuticals (CH) GmbH Name Trikafta 100 mg / 50 mg / 75 mg, 150 mg, Filmtabletten Date of registration 10.12.2020 Introduction of Sequence 10.12.2020 ATC-Classification Ivacaftor, Tezacaftor and Elexacaftor (R07AX32) Revision date WHO WHO-DDD Valid until 09.12.2025 Index Therapeuticus (BSV) 03.99. Show package size 84 Index Therapeuticus (Swissmedic) 03.99. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 13896.18 Limitation Yes Limitation text
Deductible 10 % Consumer price 14565.30 Feedback FB GTIN 7680677730016 Medication Code Synthetika Pharmacode Disponibility
Composition Filmtablette Morgendosis (elexacaftorum 100 mg / tezacaftorum 50 mg / ivacaftorum 75 mg): elexacaftorum 100 mg, tezacaftorum 50 mg, ivacaftorum 75 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, E 171, talcum, E 172 (flavum), E 172 (rubrum) pro compresso obducto corresp. natrium 2.68 mg.
Filmtablette Abenddosis (ivacaftorum 150 mg): ivacaftorum 150 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, lactosum monohydricum 167.2 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 132, cera carnauba, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 1.82 mg. Packungsbestandteile Source Data was imported : 04.02.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
